Autoimmunity Day 2023
julio 12, 2023
Senescencia y progresión a daño orgánico en las enfermedades crónicas inmunomediadas: ¿Podemos prevenirlo?
Senescencia y progresión a daño orgánico en las enfermedades crónicas inmunomediadas: ¿Podemos prevenirlo?
It is now well established that there are different life-long lung function trajectories in the general population, and that some are associated with better or worse health outcomes.
En la XXXV edición de las Jornadas Técnicas del Institut Guttmann expertos en neurorrehabilitación, en metodología XPA, en humanización y en gestión aportaron conocimientos, ideas y buenas prácticas para humanizar la gestión y la atención sanitaria en las organizaciones asistenciales.
In this expert interview, MeiLan K Han and Alvar Agustí discuss the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 executive report, which proposes a new definition for COPD and covers the latest updates in its diagnosis, management, and prevention.
Taking place on 5 July, this ERS Vision Live panel discussion will focus on new concepts in chronic obstructive pulmonary disease (COPD).
The term GETomics has been recently proposed to illustrate that human health and disease are actually the final outcome of many dynamic, interacting and cumulative gene environment interactions that occur through the lifetime of the individual.
The Global Burden of Disease Study 2017 identified that a country’s sociodemographic index was a key factor affecting mortality and loss of health from respiratory diseases.
COPD is the elephant in the room for many patients with CVDs.
Cluster analyses in NOVELTY patients with asthma and/or COPD yielded identifiable clusters, with several discriminatory features that differed from conventional diagnostic characteristics.
Chronic Obstructive Pulmonary Disease (COPD) is the third cause of death worldwide. While tobacco smoking is a key risk factor, COPD also occurs in never-smokers (NS).